Patents by Inventor Daniel Rios

Daniel Rios has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TL1A BINDING PROTEINS AND METHODS OF USE
    Publication number: 20260103531
    Abstract: Provided herein are TL1A binding proteins (e.g., antibodies that bind TL1A) and methods of use.
    Type: Application
    Filed: December 2, 2025
    Publication date: April 16, 2026
    Applicant: Paragon Therapeutics, Inc.
    Inventors: Eric Franklin Zhu, Hussam Hisham Shaheen, Daniel Rios
  • IL-17 BINDING PROTEINS, COMPOSITIONS, AND METHODS OF USE THEREOF
    Publication number: 20260070969
    Abstract: IL-17-binding proteins, related compositions, and related methods of use.
    Type: Application
    Filed: September 10, 2025
    Publication date: March 12, 2026
    Inventors: Byron Hua KWAN, Daniel RIOS, Jacob Cole MILLIGAN, Jason Zee Seug OH, Hussam Hisham SHAHEEN
  • TL1A BINDING PROTEINS AND METHODS OF USE
    Publication number: 20260055199
    Abstract: Provided herein are TL1A binding proteins (e.g., antibodies that bind TL1A) and methods of use.
    Type: Application
    Filed: October 31, 2025
    Publication date: February 26, 2026
    Applicant: Paragon Therapeutics, Inc.
    Inventors: Eric Franklin Zhu, Hussam Hisham Shaheen, Daniel Rios
  • TL1A binding proteins and methods of use
    Patent number: 12509523
    Abstract: Provided herein are TL1A binding proteins (e.g., antibodies that bind TL1A) and methods of use.
    Type: Grant
    Filed: December 30, 2024
    Date of Patent: December 30, 2025
    Assignee: Paragon Therapeutics, Inc.
    Inventors: Eric Franklin Zhu, Hussam Hisham Shaheen, Daniel Rios
  • TL1A binding proteins and methods of use
    Patent number: 12466890
    Abstract: Provided herein are TL1A binding proteins (e.g., antibodies that bind TL1A) and methods of use.
    Type: Grant
    Filed: December 30, 2024
    Date of Patent: November 11, 2025
    Assignee: Paragon Therapeutics, Inc.
    Inventors: Eric Franklin Zhu, Hussam Hisham Shaheen, Daniel Rios
  • SKIN TARGETED IMMUNOTOLERANCE
    Publication number: 20240262905
    Abstract: Methods and compounds for conferring skin-specific immune privilege.
    Type: Application
    Filed: October 15, 2021
    Publication date: August 8, 2024
    Applicant: PANDION OPERATIONS, INC.
    Inventors: Purvi MANDE, Susmita BORTHAKUR, Daniel RIOS, Nathan HIGGINSON-SCOTT, Kevin Lewis OTIPOBY, Joanne L. VINEY
  • PANCREAS TARGETED THERAPEUTICS AND USES THEREOF
    Publication number: 20240228619
    Abstract: The disclosure relates to methods and compositions for treating Type 1 diabetes, such as compositions comprising an effector domain linked to a protein that binds to MAdCAM.
    Type: Application
    Filed: February 22, 2022
    Publication date: July 11, 2024
    Applicant: PANDION OPERATIONS, INC.
    Inventors: Daniel RIOS, Kevin OTIPOBY, Joanne L. VINEY, Nathan HIGGINSON-SCOTT
  • Tissue targeted immunotolerance with a CD39 effector
    Patent number: 11981715
    Abstract: Methods and compounds for conferring site-specific or local immune privilege, such as to the skin.
    Type: Grant
    Filed: February 18, 2021
    Date of Patent: May 14, 2024
    Assignee: Pandion Operations, Inc.
    Inventors: Daniel Rios, Purvi Mande, Joanne L. Viney, Nathan Higginson-Scott, Kevin Lewis Otipoby, Susmita Borthakur, Salvatore Alioto, Lindsay J. Edwards
  • PANCREAS TARGETED THERAPEUTICS AND USES THEREOF
    Publication number: 20240132591
    Abstract: The disclosure relates to methods and compositions for treating Type 1 diabetes, such as compositions comprising an effector domain linked to a protein that binds to MAdCAM.
    Type: Application
    Filed: February 22, 2022
    Publication date: April 25, 2024
    Applicant: PANDION OPERATIONS, INC.
    Inventors: Daniel RIOS, Kevin OTIPOBY, Joanne L. VINEY, Nathan HIGGINSON-SCOTT
  • TISSUE TARGETED IMMUNOTOLERANCE WITH PD-1 AGONISTS OR IL-2 MUTEINS
    Publication number: 20230235004
    Abstract: Methods and compounds for conferring site-specific or local immune privilege.
    Type: Application
    Filed: February 19, 2021
    Publication date: July 27, 2023
    Applicant: PANDION OPERATIONS, INC.
    Inventors: Joanne L. VINEY, Nathan HIGGINSON-SCOTT, Kevin OTIPOBY, Daniel RIOS, Susmita BORTHAKUR, Salvatore ALIOTO, Lindsay EDWARDS
  • TISSUE TARGETED IMMUNOTOLERANCE WITH A CD39 EFFECTOR
    Publication number: 20210269496
    Abstract: Methods and compounds for conferring site-specific or local immune privilege, such as to the skin.
    Type: Application
    Filed: February 18, 2021
    Publication date: September 2, 2021
    Inventors: Daniel Rios, Purvi Mande, Joanne L. Viney, Nathan Higginson-Scott, Kevin Lewis Otipoby, Susmita Borthakur, Salvatore Alioto, Lindsay J. Edwards